Adma Biologics | ADMA - Operating Expenses

Stock Price
16.30
Daily Change
0.20 1.24%
Monthly
-3.89%
Yearly
5.03%
Q1 Forecast
15.60

Adma Biologics reported $83.21M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Adma Biologics USD 83.21M 4.02M Sep/2025
Alnylam Pharmaceuticals USD 965.32M 84.27M Dec/2025
BioCryst Pharmaceuticals USD -387.89M 33.7M Sep/2025
Minerva Neurosciences USD 4.52M 155.46K Dec/2024
Novavax USD 218.53M 34.86M Sep/2024
Omeros USD 59.16M 20.13M Jun/2024
Takeda JPY 1.02T 400.98B Dec/2025